NCT07408505
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Body Weight, Cancer Anorexia-Cachexia Syndrome, +2 more
- Locations
-
- Jinan, Shandong 0531 Jinan, China
Clinical trial condition
Advanced Pancreatic Ductal Adenocarcinoma
Explore clinical trials studying Advanced Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
Advanced Pancreatic Ductal Adenocarcinoma trial results
NCT06825546
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma
- Locations
-
- Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
- Henan Provincial People's Hospital Zhengzhou, Henan, China
- Hubei Cancer Hospital Wuhan, Hubei, China
- Hunan Provincial People's Hospital Changsha, Hunan, China
Not yet recruiting
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a, for Advanced Pancreatic Ductal Adenocarcinoma
NCT07619521
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
Not specified
Not yet recruiting
ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
NCT07348107
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Verspeeten Family Cancer Centre London, Ontario, Canada
Active, not recruiting
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
NCT04887805
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
NCT07021066
- Conditions
- Adenocarcinoma Of Esophagus, Advanced Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer, +9 more
- Locations
-
- HonorHealth Scottsdale, Arizona, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- University of Colorado Health Aurora, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States
Active, not recruiting
AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC
NCT05632328
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Active, not recruiting
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
NCT02921022
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Cardiovascular Diseases, Digestive System Diseases, +11 more
- Locations
-
- Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
- Miami Cancer Institute Miami, Florida, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States